Biomedical Textiles Market - Global Forecast to 2022

DUBLIN, April 4, 2018 /PRNewswire/ --

The "Biomedical Textiles Market by Fiber Type, Fabric Type, Application, and Region - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The biomedical textiles market is projected to reach USD 14.50 Billion by 2022 from 10.99 Billion in 2017, at a CAGR of 5.7% between 2017 and 2022.

The growth of this market can be attributed to the increasing use of biomedical textiles in non-implantable, implants, extracorporeal, and surgical suture applications.

The biomedical textiles market has been segmented on the basis of fabric type, fiber type, application, and region. Based on fabric type, the biomedical textiles market has been classified into non-woven, woven, and others. The non-woven segment of the biomedical textiles market is projected to grow at the highest CAGR during the forecast period. This growth can be attributed to increasing demand for non-woven fabrics from non-implantable applications, such as gauze, cohesive, adhesive, tubular, and triangular bandages.

Based on fiber type, the biomedical textiles market has been classified into biodegradable and non-biodegradable. The non-biodegradable fiber segment dominated the biomedical textiles market in 2017 due to the growing demand for non-biodegradable fibers, such as polypropylene, polyethylene, polyamide, and polyester in non-implantable applications. Non-biodegradable fibers are also widely used in many surgical sutures, implants, and extracorporeal devices.

Based on application, the biomedical textiles market has been segmented into non-implantable, surgical sutures, implants, and extracorporeal. The non-implantable application segment is expected to register the highest CAGR between 2017 and 2022. Rise in the number of surgeries and accidents globally is expected to drive the demand for biomedical textiles, including wound care products such as bandages, in the non-implantable application.

North America is estimated to be the largest market for biomedical textiles in 2017. The growth of the biomedical textiles market in North America can be attributed to the large spending on healthcare and technological innovation in healthcare products. However, the market in Asia Pacific is projected to grow at the highest CAGR between 2017 and 2022 owing to the large aging population and rise in the number of surgeries. Increasing expenditure on healthcare facilities and rising income are also propelling the growth of the biomedical textiles market in APAC.

Biomedical Textiles Market

High R&D investments and capital requirement for making biomedical textiles act as key restraints to the growth of the biomedical textiles market.

Royal DSM (Netherlands), Covidien (Ireland), Integra Life Sciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B. Braun Melsungen (Germany), and Cardinal Health (US) are the key players operating in the biomedical textiles market. These players offer a wide range of biomedical textiles to strengthen their competitive position and cater to the growing demand for biomedical textiles.

Royal DSM is one of the major players in the biomedical textiles market. The company has established a strong foothold in the biomedical textiles market by engaging itself in the various business strategies. These business strategies include partnerships and new product developments. The company manages its biomedical textiles business by providing implantable products to the medical industry.

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Data Triangulation
2.4 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Significant Opportunities in the Biomedical Textiles Market
4.2 Biomedical Textiles Market, By Application
4.3 Biomedical Textiles Market, By Country and Region
4.4 US Biomedical Textiles Market, By Application
4.5 Biomedical Textiles Market Attractiveness

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Number of Surgeries
5.2.1.2 Rapid Growth in Aging Population
5.2.1.3 High Quality of Biomedical Textiles
5.2.1.4 Growing Need for Advanced Wound Dressing Material
5.2.2 Restraints
5.2.2.1 High R&D Investments
5.2.3 Opportunities
5.2.3.1 Development of Smart Biomedical Textiles
5.2.3.2 Growing Demand From Emerging Markets
5.2.4 Challenges
5.2.4.1 Increasing Pricing Pressure on Market Players
5.2.4.2 Product Marketing
5.3 Porter's Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Industry Outlook
5.4.1 Contribution of the Healthcare Industry to GDP

6 Biomedical Textiles Market, By Fiber Type
6.1 Introduction
6.2 Non-Biodegradable Fiber
6.2.1 Polypropylene and Polyethylene
6.2.2 Cotton
6.2.3 Viscose
6.2.4 Polyester
6.2.5 Polyamide
6.2.6 Others
6.2.6.1 Polyurethane
6.2.6.2 Polytetrafluoroethylene(Ptfe)
6.3 Biodegradable Fiber
6.3.1 Collagen
6.3.2 Chitin
6.3.3 Others

7 Biomedical Textiles Market, By Fabric Type
7.1 Introduction
7.2 Non-Woven Fabric
7.3 Woven Fabric
7.4 Others
7.4.1 Knitted & Braided Fabrics
7.4.2 Hollow Fabric

8 Biomedical Textiles Market, By Application
8.1 Introduction
8.2 Non-Implantable
8.2.1 Bandages
8.3 Surgical Sutures
8.4 Others
8.4.1 Implantable
8.4.1.1 Soft Tissue Implants
8.4.1.2 Hard Tissue Implants
8.4.1.3 Dental Prosthesis
8.4.1.4 Vascular Devices
8.4.2 Extracorporeal Devices

9 Biomedical Textiles Market, By Region

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking of Key Players, 2016
10.3 Competitive Scenario
10.4 New Product Developments
10.5 Expansions
10.6 Acquisitions
10.7 Agreements & Partnerships

11 Company Profiles
11.1 Royal DSM N.V.
11.2 Medtronic PLC
11.3 Integra Lifesciences Corporation
11.4 Johnson & Johnson
11.5 Smith & Nephew PLC
11.6 Medline Industries, Inc.
11.7 B. Braun Melsungen AG
11.8 Cardinal Health, Inc.
11.9 Paul Hartmann AG
11.10 BSN Medical (A Part of Svenska Cellulosa Aktiebolaget Sca)
11.11 Other Companies
11.11.1 Atex Technologies
11.11.2 Elkem Silicones
11.11.3 Bally Ribbon Mills
11.11.4 US Biodesign
11.11.5 Nitto Denko Corporation
11.11.6 Kimberly-Clark Corporation
11.11.7 Mlnlycke Health Care
11.11.8 3M Company
11.11.9 Ahlstrom-Munksj
11.11.10 Freudenberg & Co. Kommanditgesellschaft
11.11.11 Secant Group, LLC
11.11.12 Meister & Cie Ag

For more information about this report visit https://www.researchandmarkets.com/research/b2xkx3/biomedical?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets